Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.81
-0.05 (-0.32%)
At close: Jun 20, 2025, 3:59 PM
15.80
-0.06%
After-hours: Jun 20, 2025, 05:04 PM EDT
-0.32% (1D)
Bid | 15.5 |
Market Cap | 2.7B |
Revenue (ttm) | 160K |
Net Income (ttm) | -413.84M |
EPS (ttm) | -2.73 |
PE Ratio (ttm) | -5.79 |
Forward PE | -5.54 |
Analyst | Buy |
Ask | 16.2 |
Volume | 656,770 |
Avg. Volume (20D) | 1,638,143 |
Open | 16.04 |
Previous Close | 15.86 |
Day's Range | 15.44 - 16.04 |
52-Week Range | 12.72 - 34.47 |
Beta | 0.61 |
About IMVT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMVT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMVT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+5.6%
Immunovant shares are trading higher following a Q...
Unlock content with
Pro Subscription
3 months ago
+4.29%
Immunovant shares are trading higher. B of A Securities and Guggenheim reiterated Buy ratings on the stock.